Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROI.
Andrade
Adriana
A
Flexner
Charles
C
D000480:Alkynes; D019540:Area Under Curve; D048588:Benzoxazines; D001835:Body Weight; D003521:Cyclopropanes; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D004347:Drug Interactions; D005006:Ethnicity; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010078:Oxazines / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology*; D012737:Sex Factors
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D065607:Cytochrome P-450 Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D003577:Cytochrome P-450 Enzyme System; C098320:efavirenz